Advertisements



Pharma, Biotech Bull ETFs Leading the Charge

This article was originally published on ETFTrends.com......»»

Category: topSource: foxnewsJul 12th, 2018

Sarepta Pharma Pushes Two Biotech ETFs to New Highs

The encouraging early trial results for a gene therapy for Duchenne muscular dyst.....»»

Category: smallbizSource: nytJun 20th, 2018

Deciphera Pharma Hit With Sell-Side Downgrade On Valuation After 50% Gain

Deciphera Pharmaceuticals Inc (NASDAQ: DCPH) lost a sell-side bull Tuesday, with a B. Riley FBR analyst praising the company's pipeline but concluding the biotech's positives are priced into the stock. Late.....»»

Category: blogSource: benzingaJun 19th, 2018

Pharma & Biotech ETFs Soar on Trump"s Drug Plan

Zacks.....»»

Category: topSource: redinewsMay 14th, 2018

Pharma & Biotech ETFs Soar on Trump"s Drug Plan

Trump's drug plan went in favor of pharma and biotech companies, which caused .....»»

Category: smallbizSource: nytMay 14th, 2018

Your Daily Pharma Scoop: Biotech IPO Review - Replimune, Rubius And Allakos

Your Daily Pharma Scoop: Biotech IPO Review - Replimune, Rubius And Allakos.....»»

Category: topSource: seekingalphaJul 17th, 2018

Biotech Analysis Central Pharma News: Celgene"s Protocol Change, Roche"s BLA For Herceptin, Amgen"s Resubmission For Osteoporosis

Biotech Analysis Central Pharma News: Celgene"s Protocol Change, Roche"s BLA For Herceptin, Amgen"s Resubmission For Osteoporosis.....»»

Category: topSource: seekingalphaJul 16th, 2018

Biotech Analysis Central Pharma News: Zogenix"s Late-Stage Win, Zynerba"s Bounce Back, Abbvie"s Expanded Venetoclax Use

Biotech Analysis Central Pharma News: Zogenix"s Late-Stage Win, Zynerba"s Bounce Back, Abbvie"s Expanded Venetoclax Use.....»»

Category: topSource: seekingalphaJul 16th, 2018

Biotech Analysis Central Pharma News: Cytodyn"s Acquisition, Novartis Exits Antibotic Research, Advaxis" FDA Hold Removed

Biotech Analysis Central Pharma News: Cytodyn"s Acquisition, Novartis Exits Antibotic Research, Advaxis" FDA Hold Removed.....»»

Category: topSource: seekingalphaJul 15th, 2018

Big money tests marijuana waters, with hedge funds leading charge

Navy Capital’s one-room office in midtown Manhattan could probably fit in the coat closets of many of its competitors. But the hedge fund’s digs belie the firm’s success in betting on something few of its peers will touch: cannabis......»»

Category: topSource: moneycentralJul 14th, 2018

resTORbio - Leading The Charge Against Aging Related Diseases

resTORbio - Leading The Charge Against Aging Related Diseases.....»»

Category: topSource: seekingalphaJul 13th, 2018

5 Hot Tech ETFs & Stocks Leading the Market Rally

We have highlighted the five best performing tech ETFs and stocks that have hit new highs in the latest trading session and are expected to outperform in the mo.....»»

Category: dealsSource: nytJul 13th, 2018

5 Big Reasons Why Small-Cap ETFs Are Leading

This article was originally published on ETFTrends.com......»»

Category: topSource: foxnewsJul 13th, 2018

5 Hot Tech ETFs & Stocks Leading the Market Rally

Zacks.....»»

Category: topSource: redinewsJul 13th, 2018

What Investors Need to Know about Biotech ETFs

Zacks.....»»

Category: topSource: redinewsJul 12th, 2018

What Investors Need to Know about Biotech ETFs

Smaller biotech stocks are outperforming this year; learn more about biotech ETFs best positioned to benefit Biotech sector has p.....»»

Category: personnelSource: nytJul 12th, 2018

Biotech Analysis Central Pharma News: Pfizer"s Unit Separation, BioCryst"s Merger Collapses, Scynexis" Positive Mid-Stage Results

Biotech Analysis Central Pharma News: Pfizer"s Unit Separation, BioCryst"s Merger Collapses, Scynexis" Positive Mid-Stage Results.....»»

Category: topSource: seekingalphaJul 12th, 2018

Biotech Analysis Central Pharma News: Catabasis Nears Phase 3 Start, Regulus Slashes Workforce, Cytori"s Mixed ED Data

Biotech Analysis Central Pharma News: Catabasis Nears Phase 3 Start, Regulus Slashes Workforce, Cytori"s Mixed ED Data.....»»

Category: topSource: seekingalphaJul 10th, 2018

Here"s Why This FAANG Powered ETF Can Keep Outperforming

QQQ is one of the top performing ETFs of the nine-year bull run and we discuss why it could continue its outperformance. (0:45) - Invesco T.....»»

Category: smallbizSource: nytJul 9th, 2018

Biotech ETFs Surge on Biogen"s Positive Drug Trial Result

Biotech ETFs surge on Biogen's encouraging Phase 2 clinical study data for Alzheimer???s treatment. Biogen Inc. BIIB was a star performer in Friday’s trading session, as the stock rallied as much as 23.1% but closed a l.....»»

Category: worldSource: nytJul 9th, 2018

Biotech ETFs Climb on Biogen’s Promising Clinical Trial

This article was originally published on ETFTrends.com......»»

Category: topSource: foxnewsJul 6th, 2018